ArticleCureus2025
Assessment of Serum Uric Acid Levels Among Gestational Diabetes Patients in Erbil City.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Retraction · 2025-11-20Concerns/Issues about Data · Concerns/Issues about Methods · Objections by Author(s) · Unreliable Results and/or Conclusions ·
- Retracted
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesGestational diabetes mellitus (GDM) is a common obstetrical disorder with a significant impact on maternal and fetal well-being. This study aimed to assess serum uric acid levels in pregnant women with GDM and determine their diagnostic performance.
methodsA case-control study was conducted at Erbil Maternity Hospital and primary health care units from May to December 2024, involving 200 pregnant women (100 with GDM and 100 healthy controls). Sociodemographic, obstetric, dietary, and laboratory data were collected. Serum uric acid was measured using the uricase method, and its association with GDM was evaluated using receiver operating characteristic (ROC) curve analysis and multivariable logistic regression.
resultsSerum uric acid demonstrated excellent discriminative ability for GDM (area under the curve (AUC) = 0.940). The optimal cut-off value of 3.15 mg/dL yielded 90% sensitivity and 80% specificity. Women with uric acid ≥ 3.15 mg/dL had 122.8-fold higher odds of GDM (odds ratio (OR) = 122.8, 95% confidence interval (CI): 34.4-437.8, p < 0.001) after adjusting for age, body mass index (BMI), and gestational age; each 1 mg/dL increase was associated with a 30.7-fold increase in odds (OR = 30.7, 95% CI: 10.9-86.3, p < 0.001). Elevated uric acid was present in 90% of women with GDM compared to 11% of controls. This prevalence is higher than that reported in Egypt (54.7%) and India (74.7%). Higher BMI, grand multiparity, positive family history of diabetes, and reduced plant-based food intake were also significantly associated with GDM.
conclusionElevated serum uric acid is strongly associated with GDM, with a cut-off of 3.15 mg/dL providing high diagnostic accuracy. The prevalence observed was higher than in several international studies. Limitations include the facility-based design, lack of adjustment for diet and renal function in the analysis, and potential recall bias.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.